On June 7, 2024, Biora Therapeutics, Inc. announced that it held its annual general meeting of shareholders on June 5, 2024, and declared the voting results. As no further information has been discussed between the company and Athyrium Capital Management, LP, the campaign is considered to have been withdrawn.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6501 USD | -3.79% | -6.05% | -51.84% |
06-07 | Biora Therapeutics Provides Information to the Shareholders | CI |
06-07 | Biora Therapeutics, Inc. Appoints Jeffrey A. Ferrell as Director | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-51.84% | 24.25M | |
+16.93% | 122B | |
+21.86% | 116B | |
+22.18% | 27.03B | |
-21.31% | 20.36B | |
-16.89% | 16.43B | |
-18.31% | 15.91B | |
-44.74% | 15.6B | |
+62.94% | 14.94B | |
+3.15% | 13.59B |
- Stock Market
- Equities
- BIOR Stock
- News Biora Therapeutics, Inc.
- Biora Therapeutics Provides Information to the Shareholders